FUCIDIN® IV is incompatible with:-
|
Dextrose 40% |
|
Dextrose 50% |
|
Do not infuse with whole blood or aminosol infusions. |
|
Opalescence may occur with more acidic samples of dextrose in which case the solution should be discarded. |
|
Thrombophlebitis may occur at the site of injection. |
KNOWN SYMPTOMS OF OVERDOSAGE AND PARTICULARS OF ITS TREATMENT:
See side effects. Treatment is supportive and symptomatic.
IDENTIFICATION:
FUCIDIN® IV: |
White to off-white powder in a colourless glass vial. |
FUCIDIN® IV: BUFFER: |
Clear, colourless solution in a colourless glass vial. |
PRESENTATION:
FUCIDIN® IV: |
Colourless glass vial fitted with rubber stopper, which is secured with an aluminium ring with a removable centre part, containing a powder. |
FUCIDIN®IV: BUFFER: |
Colourless glass vial fitted with rubber stopper which is secured with an aluminium ring with a removable centre part, containing a solution. |
Both vials are packed together with a package insert in a single outer carton.
STORAGE INSTRUCTIONS:
Store below 30°C. Protect from light.
Use within 24 hours once reconstituted with the buffer solution and mixed with the infusion fluid.
Keep out of reach of children.
REGISTRATION NUMBER:
FUCIDIN® IV: |
27/20.1/0065 |
FUCIDIN®IV: BUFFER: |
27/34/0066 |
NAME AND BUSINESS ADDRESS OF THE APPLICANT:
Adcock Ingram Limited
Adcock Ingram Park
17 Harrison Avenue
Bryanston Ext. 77
Private Bag X69
Bryanston
2021
DATE OF PUBLICATION OF THIS PACKAGE INSERT:
August 1993
Under licence from:
LEO PHARMACEUTICAL PRODUCTS